Blog Post
2023 – A Year in Retrospect
MEC in 4Q23: Pioneering the Future of Precision Medicine – More in 2024
The LP and The Biotech VC
Why Join a Biotech Startup?
Spinning Out? A few things to consider.
A Note (and Plea) to My Biotech Colleagues: The Healthcare Innovation Murder Mystery
Unlocking the Potential to Scale Cell Therapies: Leveraging Synthetic Biology and High-Quality Teams
Proteins: Translating Structure into Function
MEC Portfolio Company Aspen Neuroscience Featured in Wall Street Journal for Parkinson’s Disease Research
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds